CAS: 103450-87-9; Clarithromycin 9-Oxime

该化合物是合成改良的大型滑动抗生素的关键中间体,特别是在开发新颖的丙烯二烯衍生物方面,该化合物的特征是9级的氧化功能组,该组将立体化学变异作为一种E/Z混合物,其结构多功能使其对药物研究具有价值,从而能够探索强化的抗菌活性或改进的药用动力特性.该混合物通常用于对产生定向衍生物的受控反应,为研究人员提供药物设计的灵活性.高纯度等级确保合成应用的再生性,支持开发具有潜在治疗优势的下一代大型滑动抗生素.

结构式图片

MSDS等安全信息

    上下游产品

    clarithromycin formaldehyd 6-O-methyl-N-demethylerythromycin A 9-oxime 60H86N2O17C60H86N2O17clarithromycin 9-(benzylideneamino)-9-deoxo-12-deoxy-9,12-epoxy-6-O-methylerythromycin A 6-methoxyerythromycin A 9-oxime

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:WO-9928333-A1
      优先权日:1997-12-01
      标题 :Chemical synthesis of 6-o-alkyl erythromycin c
      发明人:MONTGOMERY STEPHEN H; IVES MICHAEL D; LIU JIH-HUA
      权利人:ABBOTT LAB
      摘要:A process of preparing a 6-O-alkyl derivative of erythromycin C is provided. The process includes the steps of protecting the 2',4'- and 9-oxime hydroxyls with acetyl and ketal protecting groups, alkylating the 6-hydroxyl, removing the protecting groups and deoximating. Intermediates used in the process are also provided.

      专利号:US-6369035-B1
      优先权日:1997-10-16
      标 题:3,6-hemiketals from the class of 9A-azalides
      发明人:KOBREHEL GABRIJELA; LAZAREVSKI GORJANA; VINKOVIC MLADEN
      权利人:PLIVA FARMACEUTSKA INDUSTRJA D
      摘要:The invention relates to novel compounds from the class of macrolide antibiotics. Particularly, the invention relates to novel 3,6-heiketals from the class of 9a-azalides, to their pharmaceutically acceptable addition salts with inorganic or organic acids, to a process for their preparation and to the use thereof as antibiotics or as intermediates for the synthesis of other macrolide antibiotics.

      专利号:WO-0112817-A1
      优先权日:1999-08-12
      标题:Evolution and use of enzymes for combinathorial and medicinal chemistry
      发明人:KREBBER CLAUS; DAVIS S CHRISTOPHER; DELCARDAYRE STEPHEN; SELIFONOV SERGEY A; HOWARD RUSSELL
      权利人:MAXYGEN INC; LIU LU; KREBBER CLAUS; DAVIS S CHRISTOPHER; DELCARDAYRE STEPHEN; SELIFONOV SERGEY A; HOWARD RUSSELL
      摘要:This invention provides libraries of recombinant derivatizing enzymes that are useful for biocatalytic synthesis of derivatives oforganic molecules, including lead compounds for pharmaceutical use. The recombinant derivatizing enzymes catalyze reactions such as modification or replacement of functional groups on the organicmolecules, or addition of chemical moieties onto preexisting functional groups. The use of recombinant enzyme libraries enables one to obtain enzymes that catalyze the formation of organic molecule derivatives that could not otherwise be made using only naturally occurring enzymes.

      专利号:AU-1528299-A
      优先权日:1997-12-01
      标 题 :Chemical synthesis of 6-o-alkyl erythromycin c

      专利号:AU-1416699-A
      优先权日:1997-11-17
      标题 :Chemical synthesis of 6-o-alkyl erythromycin a

      专利号:EP-1036084-A1
      优先权日:1997-12-01
      标 题 :Chemical synthesis of 6-o-alkyl erythromycin c

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      参考文献:10.1016/j.ejmech.2017.03.056
      摘要:Koštrun S, Munic Kos V, Matanović Škugor M, Palej Jakopović I, Malnar I, Dragojević S, Ralić J, Alihodžić S. Around the macrolide – Impact of 3D structure of macrocycles on lipophilicity and cellular accumulation. European Journal of Medicinal Chemistry. 2017 Jun;133():351–64. doi: 10.1016/j.ejmech.2017.03.056.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知